series-a
Stage
2021
Founded
3
Investors
About
Axonis is a neuro-focused biotechnology company developing first-in-class medicines targeting KCC2 to restore functional inhibition in the brain for treating neurological disorders such as epilepsy and pain.
Explore Axonis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.